Developing a cost-effective imaging strategy, fully integrated into a broader clinical development process, requires specific knowledge of regulatory requirements and ever-changing industry trends. Our consulting services are lead by a team with over 25 combined years experience in the use of medical imaging in clinical trials. Additional world-class imaging consulting expertise is available through the worldwide RadMD network of over 600 physicians and imaging medical physicists.

When independent image evaluations (“blinded reads”) are used in trials, it is critical that physicians performing the evaluations have expertise in the disease process. Our blinded reader sourcing service matches the most qualified physicians to individual studies, with the largest global network of physicians who have undergone standardized training as blinded readers. This translates into faster image evaluations by the most qualified personnel for your trials.
In the News
JUNE 29, 2015
Kohkan Shamsi, M.D., Ph.D., Presents at CTAD 2015 in Barcelona, Spain - Abstract Title: Increased Utilization of Imaging in Alzheimer Disease (AD) Trials: Impact on Patient Recruitment, Retention and Logistics
read more
JUNE 29, 2015
Kohkan Shamsi, M.D., Ph.D., Presents at XXII World Congress of Neurology (WCN 2015) in Santiago, Chile - Abstract Title: Imaging in Alzheimer Disease (AD) Trials
read more
MARCH 10, 2015
RSNA 2014 Abstract: Evaluation of a New Manganese-based Orally-Administered Hepatobiliary MR Contrast Agent
read more
MARCH 09, 2015
RadMD Presents at ECR 2015: Comparison of a New Manganese-Based Orally-Administered Hepatobiliary MR Contrast Agent with Gd-Chelate-enhanced MR Images for the Evaluation of Focal Liver Lesions
read more
 
Who We Are Services BRITI News Contact Us
Consulting Sourcing BRITI